Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Return on Equity (2021 - 2025)

Rani Therapeutics Holdings (RANI) has 5 years of Return on Equity data on record, last reported at 4.51% in Q3 2025.

  • For Q3 2025, Return on Equity rose 1420.0% year-over-year to 4.51%; the TTM value through Sep 2025 reached 4.51%, up 1420.0%, while the annual FY2024 figure was 3.91%, 255.0% down from the prior year.
  • Return on Equity reached 4.51% in Q3 2025 per RANI's latest filing, down from 7.23% in the prior quarter.
  • Across five years, Return on Equity topped out at 58.77% in Q1 2025 and bottomed at 12.21% in Q4 2024.
  • Average Return on Equity over 5 years is 1.0%, with a median of 0.79% recorded in 2022.
  • Peak YoY movement for Return on Equity: crashed -996bps in 2024, then surged 6207bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.42% in 2021, then tumbled by -88bps to 0.79% in 2022, then tumbled by -186bps to 2.25% in 2023, then crashed by -442bps to 12.21% in 2024, then surged by 137bps to 4.51% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 4.51% in Q3 2025, 7.23% in Q2 2025, and 58.77% in Q1 2025.